EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Efficacy of prophylactic tranexamic acid among parturient at increased risk for postpartum hemorrhage undergoing cesarean delivery: A systematic review and meta-analyses of randomized controlled trials

Mohamed Aziz Daghmouri iD, Simon Crequit, Amelie Madeuf, Wael Chaabane, Ortéga Laurent, Patrick Lafforgue, Bechir Azzouzi, Ines Ouaz, Mohamed Ali Chaouch

PLOS One · 09.10.2025 · 20 (10) · e0333177

DOI: 10.1371/journal.pone.0333177 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS One, online erschienen am 09.10.2025. Verfasst von Mohamed Aziz Daghmouri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Montreuil Intercommunal Hospital Center, Montreuil, France. Hauptthemen laut MEDLINE: Tranexamic Acid, Postpartum Hemorrhage, Cesarean Section, Antifibrinolytic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postpartum hemorrhage (PPH) remains a significant cause of maternal morbidity and mortality worldwide. Prophylactic pharmacological interventions, especially tranexamic acid (TXA), are under evaluation for their efficacy in preventing PPH during cesarean sections in high-risk women. This systematic review and meta-analysis aimed to assess the effectiveness of prophylactic tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery.

Methods

This systematic review and meta-analysis followed the PRISMA 2020 guidelines and was registered in the PROSPERO database (ID: CRD42024520613). We conducted a comprehensive search in several bibliographic databases for randomized controlled trials comparing prophylactic tranexamic acid to placebo in parturients at increased risk for PPH undergoing cesarean delivery published until 1 st , 2024. We sought trials in the United States National Library of Medicine, Cochrane Database of Systematic Reviews (CDSR) and the Cochrane Central Register of Controlled Trials (CENTRAL), Embase, National Institutes of Health PubMed/MEDLINE, Web of Science, and Google Scholar databases. Primary outcomes included intraoperative blood loss, while secondary outcomes covered hemoglobin loss, transfusion needs, the incidence of PPH, and side effects.

Results

Eleven randomized controlled trials involving 1627 patients were included. The meta-analysis revealed that TXA significantly reduces intraoperative blood loss compared to placebo (Mean Difference (MD) = −343.89, 95% CI [−394.34, −293.43], p < 0.00001). Furthermore, TXA was associated with lower rates of blood transfusions and PPH. The heterogeneity was substantial across studies but reduced significantly in subgroup analyses. No significant differences in side effects, hysterectomy, or additional uterotonic use were observed between the two groups.

Conclusions

Prophylactic tranexamic acid significantly reduces intraoperative blood loss and the incidence of PPH in parturients at increased risk undergoing cesarean delivery, without increasing side effects. These findings support the broader use of TXA in this high-risk group, although further research is necessary to explore long-term outcomes and optimal administration protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidPostpartum HemorrhageCesarean SectionAntifibrinolytic AgentsHumansFemalePregnancyRandomized Controlled Trials as TopicBlood Loss, SurgicalRisk Factors

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Anesthesia, Montreuil Intercommunal Hospital Center, Montreuil, France.
  • Department of Gynecology, Montreuil Intercommunal Hospital Center, Montreuil, France.
  • Department of Gynecology, Perpignan Hospital Center, Perpignan, France.
  • Department of Emergency, Perpignan Hospital Center, Perpignan, France.
  • Department of Visceral and Digestive Surgery, Monastir University Hospital, Monastir, Tunisia.

ORCID-Profile: Mohamed Aziz Daghmouri

Zitieren

APA

Daghmouri, M. A., Crequit, S., Madeuf, A., Chaabane, W., Laurent, O., Lafforgue, P., Azzouzi, B., Ouaz, I., & Chaouch, M. A. (2025). Efficacy of prophylactic tranexamic acid among parturient at increased risk for postpartum hemorrhage undergoing cesarean delivery: A systematic review and meta-analyses of randomized controlled trials. PLOS One, 20(10), e0333177. https://doi.org/10.1371/journal.pone.0333177

Vancouver

Daghmouri MA, Crequit S, Madeuf A, Chaabane W, Laurent O, Lafforgue P, et al. Efficacy of prophylactic tranexamic acid among parturient at increased risk for postpartum hemorrhage undergoing cesarean delivery: A systematic review and meta-analyses of randomized controlled trials. PLOS One. 2025;20(10):e0333177. doi:10.1371/journal.pone.0333177

BibTeX
@article{Daghmouri2025,
  author = {Daghmouri, Mohamed Aziz and Crequit, Simon and Madeuf, Amelie and Chaabane, Wael and Laurent, Ortéga and Lafforgue, Patrick and Azzouzi, Bechir and Ouaz, Ines and Chaouch, Mohamed Ali},
  title = {Efficacy of prophylactic tranexamic acid among parturient at increased risk for postpartum hemorrhage undergoing cesarean delivery: A systematic review and meta-analyses of randomized controlled trials},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {10},
  pages = {e0333177},
  doi = {10.1371/journal.pone.0333177}
}
Kostenlos starten →